[Correspondence] Low-dose CT for lung cancer screening

We read with great interest the Policy Review by Oudkerk and colleagues,1 but we do not agree with their conclusion that lung cancer screening should be implemented in Europe. We strongly believe that the available evidence does not show that the benefits of lung cancer screening with low-dose CT are greater than the harms. Instead, a first step that could effectively reduce the lung cancer burden would be to fund treatments and programmes to stop smoking. In addition to reducing the incidence of lung cancer, the incidence of other cancers would also be affected, as well as the incidence of respiratory and cardiovascular diseases.
Source: The Lancet Oncology - Category: Cancer & Oncology Authors: Tags: Correspondence Source Type: research